Co-Authors
This is a "connection" page, showing publications co-authored by Anjan Trikha and Milind Nadkar.
Connection Strength
0.059
-
A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19. Expert Opin Biol Ther. 2021 05; 21(5):675-686.
Score: 0.059
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.